A flavonoid from medicinal plants blocks hepatitis B virus-e antigen secretion in HBV-infected hepatocytes

Antiviral Res. 2005 Sep;67(3):163-8. doi: 10.1016/j.antiviral.2005.06.005.

Abstract

A flavonoid molecule that showed a unique anti-HBV function was isolated from Phyllanthus urinaria. The molecular formula was determined as C14H6O8 based on FAM-MS analysis and the structure was determined by NMR. The identified flavonoid molecule, ellagic acid, showed unique anti-HBV functions. Ellagic acid did not inhibit either HBV polymerase activity, HBV replication or block HBsAg secretion. Rather, ellagic acid blocks effectively HBeAg secretion in HepG2 2.2.15 cells (IC50=0.07 microg/ml). Since HBeAg is involved in immune tolerance during HBV infection, ellagic acid, a newly identified functional anti-HBV compound, may be a new candidate therapeutic against immune tolerance in HBV-infected individuals.

MeSH terms

  • Antiviral Agents / pharmacology*
  • Cell Line
  • Ellagic Acid / chemistry
  • Ellagic Acid / isolation & purification
  • Ellagic Acid / pharmacology*
  • Gene Products, pol / analysis
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis B e Antigens / analysis*
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / physiology
  • Hepatocytes / virology*
  • Humans
  • Magnetic Resonance Spectroscopy
  • Mass Spectrometry
  • Molecular Structure
  • Phyllanthus / chemistry*
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Gene Products, pol
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • P protein, Hepatitis B virus
  • Plant Extracts
  • Ellagic Acid